Matches in Wikidata for { <http://www.wikidata.org/entity/Q81502132> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q81502132 description "article scientifique publié en 2008" @default.
- Q81502132 description "artículu científicu espublizáu en xunu de 2008" @default.
- Q81502132 description "im Juni 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81502132 description "scientific article published on 13 June 2008" @default.
- Q81502132 description "wetenschappelijk artikel" @default.
- Q81502132 description "наукова стаття, опублікована в червні 2008" @default.
- Q81502132 name "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 name "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 type Item @default.
- Q81502132 label "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 label "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 prefLabel "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 prefLabel "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 P1433 Q81502132-AB092D15-9FAD-418E-9BEF-9707666D9D93 @default.
- Q81502132 P1476 Q81502132-A6E330EA-8EB6-4C0A-AF7B-87DED41C8B2D @default.
- Q81502132 P2093 Q81502132-47754ED4-7895-4772-AA69-6B4F786079E1 @default.
- Q81502132 P2093 Q81502132-F887DA35-F92F-4576-A1E2-C1233E0751C0 @default.
- Q81502132 P304 Q81502132-3D5E2F08-DD3D-4E43-AF17-3D233537D39F @default.
- Q81502132 P31 Q81502132-3EA363AB-C8B4-44F9-9C05-E5BA992AFE5A @default.
- Q81502132 P31 Q81502132-487eca0c-37a0-45b8-8cef-acf2691bd566 @default.
- Q81502132 P356 Q81502132-D220FF78-480E-4868-BFBC-E7ACFEC8DA29 @default.
- Q81502132 P433 Q81502132-0522CA0A-8396-4CF8-A020-E33B40D966E7 @default.
- Q81502132 P478 Q81502132-21F956EA-1765-4E8E-A590-83C4E4C6D7A8 @default.
- Q81502132 P577 Q81502132-8282586A-50A0-49A1-8008-A2CF4A8D61CE @default.
- Q81502132 P698 Q81502132-52F42876-C14C-461A-91DC-366F22D255D8 @default.
- Q81502132 P356 J.EURURO.2008.06.018 @default.
- Q81502132 P698 18571304 @default.
- Q81502132 P1433 Q15763991 @default.
- Q81502132 P1476 "Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature" @default.
- Q81502132 P2093 "Christian Gratzke" @default.
- Q81502132 P2093 "Oliver Reich" @default.
- Q81502132 P304 "776-777" @default.
- Q81502132 P31 Q13442814 @default.
- Q81502132 P31 Q871232 @default.
- Q81502132 P356 "10.1016/J.EURURO.2008.06.018" @default.
- Q81502132 P433 "4" @default.
- Q81502132 P478 "54" @default.
- Q81502132 P577 "2008-06-13T00:00:00Z" @default.
- Q81502132 P698 "18571304" @default.